Publicação científica trimestral do CREMERJ - número 4 - 2022

84 Microbioma e doença pulmonar obstrutiva crônica Hisbello da Silva Campos Med. Ciên. e Arte , Rio de Janeiro, v.1, n.4, p.74-85, out-dez 2022 32. Gao Z, Kang Y, Yu J, Ren L. Human pharyngeal microbiome may play a protective role in respiratory tract infections. Genom Proteom Bioinf 2014;12(3):144-150. 33. Biesbroek G, Tsivtsivadze E, Sanders EA, Montijn R, Veenhoven RH, Keijser BJ, Bogaert D. Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. Am J Respir Crit Care Med 2014;190(11):1283-1292. 34. Kelly BJ, Imai I, Bittinger K, Laughlin A, Fuchs BD, Bushman FD, Collman RG. Composition and dynamics of the respiratory tract microbiome in intubated patients. Microbiome 2016; 4(1):7. 35. Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB. The microbiome and the respiratory tract. Annu Rev Physiol 2016; 78:481-504. 36. Global Initiative for Chronic Obstructive Lung Disease – GOLD. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Gold Report 2021. 37. Halpin DMG, Celli BR, Criner GI et cols. The GOLD Summit on chronic obstructive pulmonar disease in low- and Middle-income countries. Int J Tuberc Lung Dis 2019;23(11):1131-41. 38. Mathes CD, Loncar D. Projections of global mortality and burden of desease from 2002 to 2030. PLoS Med 2006;3(11):e442. 39. Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Lancet Respir Med 2022;10(5):497-511. 40. Wood AM, Stockley RA. The genetics of chronic obstructive pulmonar disease. Respir Res 2006 ;7(1):130. 41. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23(6):932-46. 42. ATS: Chronic bronchitis, asthma and pulmonary emphysema: a statement by the committee on diagnostic standards for non-tuberculous respiratory diseases. Am Rev Resp Dis 1962, 85:762-768. 43. Snider GL, Kleineman J, ThurlbeckWM, Bengali ZK: The definition of emphysema: a report of the National Heart, Lung and Blood Institute, Division of Lung Diseases Workshop. Am Rev Resp Dis 1985, 132:182-185. 44. Agusti AG. Systemic effects of chronic obstructive pulmonar disease. Proc Am Thorac Soc 2005, 2(4):367- 70; discussion 371-2. 45. Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Curr Opin Gastroenterol 2015;31(1):69-75. 46. Samuelson DR, Welsh DA, Shellito JE. Regulation of lung immunity and host defense by the intestinal microbiota. Frontiers in Microbiology 2015;6:1085. 47. Li J, Jia H, Cai X et cols. MetaHIT Consortium. An integrated catalog of reference genes in the human gut microbiome. Nat Bio Technol 2014;32:834-841. 48. Chunxi L, Haiyue L,Yanxia L et cols. The Gut Microbiota and Respiratory Diseases: New Evidence. J Immunol Res 2020;2020:2340670. 49. Mammen MJ, Sethi S. COPD and the microbiome. Respirology 2016;21:590-9. 50. Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the ‘healthy’ smoker and in COPD. PLoS ONE 2011; 6: e16384. 51. Sze MA, Dimitriu PA, Hayashi S et cols. The lung tissue microbiome in chronic obstructive pulmonar disease. J Clin Microbiol 2012;50:3562-8. 52. Grunig G, Baghdassarian A, Park S-H et cols. Challenges and current efforts in the development of biomarker for chronic inflammatory and remodeling conditions of the lungs. Biomarker Insights 2015;10(S4):59-72. 53. Sin DD, Miller BE, Duvoix A, et al. ECLIPSE Investigators. SerumPARC/ CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(9):1187-92. 54. Agustí A, Edwards LD, Rennard SI, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012;7(5):e37483.

RkJQdWJsaXNoZXIy ODA0MDU2